Head Of India’s Sun Says No Plans To Shut Taro Plants If Buy Succeeds
This article was originally published in PharmAsia News
Executive Summary
Reports to the contrary, India's Sun Pharmaceutical Industries said it has no plan to close the Israeli plant of Taro Pharmaceutical if a hostile takeover goes through. Sun's chairman and managing director, Dilip Shanghvi, said Sun plans to make maximum use of all Taro facilities if the acquisition is completed. The Indian company is still fighting in courts on two continents for a controlling interest in Taro. (Click here for more